Parkway Life Real Estate Investment Trust (C2PU) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
6 Jun, 2025Executive summary
FY2024 distributable income rose 2.3% year-over-year to S$91.4 million, with DPU up 1.0% to 14.92 cents; excluding equity fund raising, DPU would have increased 2.3% to 15.11 cents.
Gross revenue and net property income declined 1.5% and 1.8% year-over-year, mainly due to JPY depreciation, partially offset by new acquisitions in Japan and France.
Major acquisitions included one nursing home in Japan (August 2024) and eleven nursing homes in France (December 2024), fully funded by an oversubscribed S$180m equity fund raising.
Portfolio expanded to 75 properties across Singapore, Japan, Malaysia, and France, valued at S$2.46 billion as of 31 December 2024.
67.2% of rental income tied to CPI-based revisions, providing inflation hedging.
Financial highlights
FY2024 gross revenue: S$145.3m (-1.5% year-over-year); net property income: S$136.6m (-1.8%).
2H2024 DPU: 7.38 cents (-1.3% year-over-year), impacted by enlarged unit base from equity fund raising.
Net income after tax for FY2024 was S$95.0 million, down from S$100.5 million in FY2023.
Net asset value per unit: S$2.41 (Group), S$2.54 (Trust); unit price at S$3.75, a 55.6% premium to NAV.
Gearing at 34.8% with interest cover of 9.8x and all-in debt cost of 1.48%.
Outlook and guidance
No long-term debt refinancing needs until September 2026; ample debt headroom before regulatory gearing limits.
87% of borrowings/interest rate exposure hedged as of year-end; FX risks managed via JPY forward contracts and natural hedges.
Focus on strengthening existing markets, building a third key market (Europe), and fostering strategic partnerships for mid- to long-term growth.
Portfolio expected to benefit from resilient healthcare and aged care demand, supported by demographic trends.
Latest events from Parkway Life Real Estate Investment Trust
- Revenue and NPI rose over 7%, with DPU up 2.5% and strong portfolio expansion.C2PU
Q4 20252 Feb 2026 - Revenue and income rose on acquisitions and lease growth, with strong balance sheet metrics.C2PU
Q3 20255 Nov 2025 - Revenue and income rose on new acquisitions, with stable leverage and inflation hedges.C2PU
Q2 20256 Aug 2025 - DPU growth, France expansion, and robust risk management drive PLife REIT's resilient performance.C2PU
Investor Presentation13 Jun 2025 - Acquisition of 11 French nursing homes accelerates ParkwayLife REIT's European expansion.C2PU
Investor Presentation13 Jun 2025 - DPU grew 2.8% year-over-year despite revenue decline, supported by FX hedges and new acquisitions.C2PU
Q3 202413 Jun 2025 - Distributable income and DPU rose 3.5% despite revenue decline from currency headwinds.C2PU
H1 202413 Jun 2025 - S$2.23B healthcare REIT with robust leases, high occupancy, and consistent DPU growth.C2PU
Investor Presentation13 Jun 2025 - 1Q 2025 saw strong revenue and income growth, supported by new acquisitions and prudent risk management.C2PU
Q1 20256 Jun 2025